Answers are grounded in this paper and cite their sources.
PR3-ANCA is highly specific for UC. The differentiating capability of a panel, which contains PR3-ANCA and weighs broadly available antibodies, is superior and utilization of the panel can support accurate classification in the work-up of pediatric and adolescent patients with IBD patients.
No takes yet. Share an insight, caveat, or question.
Horn et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: